HOXC6 and cancer: The GSEA result showed that it is significantly related to cancer survival, oncogenesis by met, gemcitabine resistance, response to UV, HOXC6 targets cancer, recurrent liver cancer, WTAP targets, tumor differentiated well vs. poorly, epithelial mesenchymal transition, hypoxia pathway, TGFB1 targets, cancer meta signature, and so on (Supplementary Table S7).